Home - GT Molecular

GT Molecular Wins CDC's NWSS Multi-Pathogen Assay Development Contract

Please reach out to us to learn more or to be added to our update list for new and upcoming CDC assay kit releases!

Learn More Request Updates

High-Performance PCR Kits for Cancer Research, Pathogen Testing, and Wastewater Surveillance

All-in-one multiplex digital and RT-qPCR assays and panels to accelerate your research program

Identify the pathogens circulating in your community

Our ultra-sensitive pathogen PCR tests can detect as few as one to three nucleic acid fragments of Influenza A/B, SARS-CoV-2, RSV, mpox, and many other pathogens in wastewater samples. Our testing services customers receive data within 24 to 48 hours after sample receipt.

See Assay Kits See Testing Services

Rapid Wastewater
Testing Services

Fast and easy wastewater testing for SARS-CoV-2, Influenza, mpox, RSV and more for accurate wastewater pathogen surveillance

Learn More

Water & Wastewater Testing Water & Wastewater Assay Kits Cancer Research Infectious Disease Cannabis Foundational & Translational Research

Who we are

GT Molecular was created to develop new molecular detection technologies for cancer research and pathogen detection. We recently leveraged these powerful tools to support communities around the country with their SARS-CoV-2 wastewater monitoring programs.

We design ultra-sensitive digital PCR, qPCR, and next-generation sequencing assays, illicit drug detection tests, and end-to-end solutions for cancer genotyping and waterborne pathogen detection including SARS-CoV-2.

Learn More

Products and Applications

All-in-One Multiplex PCR Test Kits

PCR Pathogen Testing for COVID, Influenza, RSV,
Polio, and Other Pathogens

See Assay Kits

Testing Services

Wastewater Surveillance & Testing Services

SARS-CoV-2, Influenza A/B, RSV, Mpox, Other Pathogens, Illicit Drugs, and Next-Generation Sequencing

See Services

Applications

SARS-CoV-2 | COVID-19 | Variants

Pathogen detection

Genetically Modified Organisms (GMOs)

Rare sequence detection in cancer and disease

Gene expression analysis

Next-Generation Sequencing (NGS)

Learn More

Our clients

Hospitals and Pathology Laboratories

Research Laboratories and Academic Institutions

Clinical Research Organizations

Pharmaceutical and Biotechnology

Forensic Laboratories

Municipalities and Wastewater Treatment Facilities

What people are saying about us

MIT Technology Review recognizes GT Molecular as the first lab to identify the SARS-CoV-2 UK variant signature in US sewersheds while helping communities track virus progression

Read the Article